Evaluate the Efficacy and Safety of DWJ1506 and DWJ1507
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 280 participants.
Also called NCT04772443
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 280 participants
- Registry
-
NCT04772443
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Unknown status
Technical summary
Registry record NCT04772443. Randomized; quadruple masking; primary purpose treatment. Start 2021-02 (anticipated); primary completion 2022-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Evaluate the Efficacy and Safety of DWJ1506 and DWJ1507
- Condition
- Dyslipidemias
- Intervention (Drug)
- DWJ1506
- Intervention (Drug)
- DWJ1507
- Intervention (Drug)
- DWC202011
- Intervention (Drug)
- DWJ1177
- Lead sponsor
- Daewoong Pharmaceutical Co. LTD.
Record details
- Record id
cardio:ct-nct04772443- Content hash
3a0695cb476509b5d6c81ec9e3e7184d254853ef23e6a34b89cb0a54e214313f